Literature DB >> 7724125

Endovascular stent placement and magnetic resonance angiography for management of hypertension and renal artery occlusion during pregnancy.

T T Le1, Z J Haskal, G A Holland, R Townsend.   

Abstract

BACKGROUND: Severe renovascular hypertension carries serious maternal and fetal risk. In patients failing medical therapy, therapeutic options include surgical revascularization, nephrectomy, and percutaneous angioplasty. CASE: A pregnant woman with long-standing hypertension developed accelerated hypertension despite multiple drug therapy. Magnetic resonance angiography diagnosed an atrophic kidney with a critical proximal right renal artery lesion. At 17 weeks' gestation, this renal artery occlusion was treated with percutaneous angioplasty and endovascular stent placement; hypertension has improved markedly, allowing discontinuation and tapering of her antihypertensive medications. Total fetal radiation dose was 0.002 Gy.
CONCLUSION: Magnetic resonance angiography is a promising, noninvasive diagnostic method of evaluating renovascular hypertension during pregnancy. Transluminal angioplasty and endovascular stent placement can be performed safely and effectively with nominal fetal radiation exposure.

Entities:  

Mesh:

Year:  1995        PMID: 7724125     DOI: 10.1016/0029-7844(94)00461-l

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  2 in total

1.  Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium.

Authors:  Xing-ju Liu; Shuo Wang; Yuan-li Zhao; Mario Teo; Peng Guo; Dong Zhang; Rong Wang; Yong Cao; Xun Ye; Shuai Kang; Ji-Zong Zhao
Journal:  Neurology       Date:  2014-04-23       Impact factor: 9.910

Review 2.  The implications of ISAT and ISUIA for the management of cerebral aneurysms during pregnancy.

Authors:  Laurence A G Marshman; A Robert Aspoas; Manjit S Rai; Sanjiv J Chawda
Journal:  Neurosurg Rev       Date:  2007-05-17       Impact factor: 2.800

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.